Daniel Givens, MD
Otolaryngology · Dubuque, IANPI 1821223165
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Galderma Laboratories, L.p. at 33.5% of the total.
Across 60 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$439
- Stryker$166
- Convatec Inc.$97
- Revance Therapeutics, Inc.$95
- Smith+Nephew$72
- Aerin Medical Inc.$65
- plus $376 from 12 others
What the payments were for
- Food & beverage$1,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 21 | $439 |
| Stryker | 5 | $166 |
| Convatec Inc. | 4 | $97 |
| Revance Therapeutics, Inc. | 2 | $95 |
| Smith+Nephew | 4 | $72 |
| Aerin Medical Inc. | 6 | $65 |
| Alk-abello, Inc | 3 | $57 |
| Optinose US, Inc. | 3 | $45 |
| Intersect ENT, Inc. | 2 | $44 |
| Sanofi | 2 | $43 |
| Acclarent, Inc | 1 | $39 |
| KARL Storz Endoscopy-america | 1 | $33 |
| Neurent Medical Limited | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Medtronic | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $16 |
| Medline Industries LP | 1 | $14 |
| Kaleo, Inc. | 1 | $13 |
How this compares
$1,310 in reported general payments places this provider in the 60th percentile of 103 otolaryngology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 106 | $3,361 |
| Arnuity ElliptaFluticasone Furoate | 11 | $2,214 |
| Fluticasone Propionate | 136 | $1,552 |
| Ofloxacin | 36 | $1,142 |
| Mupirocin | 90 | $826 |
| Omeprazole | 109 | $771 |
| Azelastine Hcl | 39 | $668 |
| Dexamethasone Sodium Phosphate | 11 | $487 |
| Doxycycline Monohydrate | 19 | $380 |
| Pantoprazole Sodium | 22 | $316 |
| Cephalexin | 37 | $216 |
| Prednisone | 29 | $150 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $137 |
| ValacyclovirValacyclovir Hcl | 13 | $130 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $91 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Dubuque
- Tyler Willman SrDubuque$1K
- Thomas BendaDubuque$875
- Gregory WhiteDubuque$634
- Thomas HeinemanCedar Rapids$373K
- Bruce GantzIowa City$170K
- Nancy BaumanIowa City$31K
- Simon WrightWest Des Moines$21K
- Robert PettisOskaloosa$10K
- Brian AndrewsIowa City$9K
- Douglas HoisingtonWest Des Moines$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.